AtheroGenics, Inc. (AGIX) CMO Encouraged By Early Results
AtheroGenics, Inc. (NASDAQ: AGIX), a pharmaceutical company focused on the treatment of chronic inflammatory diseases, released news earlier this morning…
AtheroGenics, Inc. (NASDAQ: AGIX), a pharmaceutical company focused on the treatment of chronic inflammatory diseases, released news earlier this morning…
There is a reason that some people have chosen to go into the trash hauling game. Trash needs to go…
Red Lake Exploration announced a summarization of its results of the contract mining regarding its Santa Rosa copper-gold property in…
eDOORWAYS Corporation (EDWY.OB) is in the process of building a highly experienced management team. The company is targeting and approaching…
In today's technologically advanced society, you would be hard pressed to find someone who does not own a cellular phone.…
Technically, this stock is part of the Mobile Homes & RVs Industry in the Capital Goods Sector. Such a narrow…
This stock has traded at the end of the second week of April 2008 at just $5.70. The Price to…
Cal-Maine Foods, Inc. (CALM.OB), the largest poultry-egg producer in the United States, announced that the company will commence its new…
Intellect Neurosciences, Inc. (OTCBB: ILNS) announced that they have completed the grant requirements to obtain a European patent regarding the…
Transition Therapeutics Inc. (TTHI), based in Toronto, Ontario, Canada, is a biopharmaceutical company that develops novel therapeutics for diseases which…